Editorial: Immunogenicity of Proteins Used as Therapeutics

• Zuben E. Sauna,
• Susan M. Richards,
• Bernard Maillere,
• Elizabeth C. Jury,
• Amy S. Rosenberg

Affiliations

Zuben E. Sauna

Hemostasis Branch, Division of Plasma Protein Therapeutics, Office of Tissues and Advanced Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States

Susan M. Richards

Translational Medicine and Early Development, Sanofi Research and Development, Sanofi, Framingham, MA, United States

Bernard Maillere

Université de Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé, SIMoS, Gif-sur-Yvette, France

Elizabeth C. Jury

Centre for Rheumatology, Division of Medicine, University College London, London, United Kingdom

Amy S. Rosenberg

Laboratory of Immunology, Division of Biotechnology Product Review and Research 3, Office of Biotechnology Products, Center for Drugs Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States